Type 2 diabetes mellitus and skeletal muscle metabolic function

Area of Science:

• Metabolic disorders
• Skeletal muscle physiology
• Mitochondrial function

Background:

• Type 2 diabetic patients exhibit reduced fat oxidation and elevated free fatty acids (FFAs), leading to skeletal muscle insulin resistance.
• Impaired metabolic flexibility, the inability to switch fuel sources, is a hallmark of type 2 diabetes.
• Skeletal muscle insulin resistance is exacerbated by reduced fat oxidative capacity and impaired metabolic flexibility.

Purpose of the Study:

• To investigate the role of mitochondrial function in skeletal muscle insulin resistance in type 2 diabetes.
• To reconcile conflicting evidence regarding mitochondrial capacity in type 2 diabetic skeletal muscle.

Main Methods:

• In vivo 31-Phosphorus Magnetic Resonance Spectroscopy (31P-MRS) to assess mitochondrial oxidative capacity in skeletal muscle.
• Ex vivo high-resolution respirometry to quantify mitochondrial function.

Main Results:

• In vivo studies indicated decreased mitochondrial oxidative capacity in skeletal muscle of type 2 diabetic patients.
• Ex vivo respirometry yielded contradictory results, suggesting preserved mitochondrial function.

Conclusions:

• The precise role of mitochondrial dysfunction in type 2 diabetes-related insulin resistance requires further investigation.
• Future studies should clarify whether mitochondria are functionally impaired or reduced in number, and if this is a primary cause or a feature of insulin resistance.